Dorothée Sémiond
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 28
- Cancer Treatment and Pharmacology 15
- Peptidase Inhibition and Analysis 8
- Drug Transport and Resistance Mechanisms 5
- Hematology 22
- Multiple Myeloma Research and Treatments 22
- Co-authors
- Patricia Vrignaud (3 shared papers)Hervé Bouchard (2 shared papers)Marie-Christine Bissery (2 shared papers)M Besenval (2 shared papers)Alain C. Mita (1 shared paper)Eric K. Rowinsky (1 shared paper)Anthony W. Tolcher (1 shared paper)Johann S. de Bono (1 shared paper)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (5 papers)Blood (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)European Journal of Cancer (3 papers)Annals of Oncology (3 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Dorothée Sémiond
41 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Hematology 319
- Oncology 612
- Pulmonary and Respiratory Medicine 482
- Cancer Research 163
- Biomaterials 126
Countries citing papers authored by Dorothée Sémiond
This map shows the geographic impact of Dorothée Sémiond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothée Sémiond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothée Sémiond more than expected).
Fields of papers citing papers by Dorothée Sémiond
This network shows the impact of papers produced by Dorothée Sémiond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothée Sémiond. The network helps show where Dorothée Sémiond may publish in the future.
Co-authors
The 25 scholars most cited alongside Dorothée Sémiond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 260 | |
| 2 | 2013 | 191 | |
| 3 | 2003 | 93 | |
| 4 | 2005 | 69 | |
| 5 | 2014 | 66 | |
| 6 | 2019 | 66 | |
| 7 | 2011 | 51 | |
| 8 | 2012 | 47 | |
| 9 | 2020 | 44 | |
| 10 | 2002 | 37 | |
| 11 | 2018 | 35 | |
| 12 | 2013 | 34 | |
| 13 | 2013 | 28 | |
| 14 | 2005 | 25 | |
| 15 | 2013 | 21 | |
| 16 | 2020 | 21 | |
| 17 | 2006 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2014 | 13 | |
| 20 | A bridging study of fananserin in schizophrenic patients. | 1998 | 10 |
About Dorothée Sémiond
Dorothée Sémiond is a scholar working on Oncology, Hematology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (22 papers), Cancer Treatment and Pharmacology (15 papers), Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer therapeutics and mechanisms (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Hematology (319 citations), Oncology (612 citations), Pulmonary and Respiratory Medicine (482 citations), Cancer Research (163 citations) and Biomaterials (126 citations). Dorothée Sémiond has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Patricia Vrignaud, Hervé Bouchard, Marie-Christine Bissery, M Besenval, Alain C. Mita, Eric K. Rowinsky, Anthony W. Tolcher, Johann S. de Bono, Amita Patnaik and Louis Denis. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, Blood, Cancer Chemotherapy and Pharmacology, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.